Has Barbara Craft, MD received payments from drug or device companies?

Yes. Drug and device makers reported $134,698 in general payments to Barbara Craft, MD across 635 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Barbara Craft, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Barbara Craft, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Barbara Craft, MD

Hematology & Oncology · Jackson, MSNPI 1104862259

Payments from drug & device makers

$134,698in general payments, 2019–2025

Across 635 payments — averaging $212.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$102K
Pfizer$23K
AstraZeneca$980
Gilead$864
Johnson & Johnson$567
Novartis$562
plus $7K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	26	$101,670
Pfizer	53	$22,666
AstraZeneca(2 entities)	50	$980
Gilead(2 entities)	28	$864
Johnson & Johnson(2 entities)	43	$567
Novartis	39	$562
Daiichi Sankyo Inc.	20	$562
Incyte Corporation	23	$438
Amgen	26	$408
Astellas Pharma US Inc	19	$403
Puma Biotechnology, Inc.	29	$402
Bristol Myers Squibb	17	$363
Takeda Pharmaceuticals U.S.A., Inc.	18	$329
Genentech USA, Inc.	16	$263
AbbVie	11	$227
Rigel Pharmaceuticals, Inc.	9	$226
Seagen Inc.	9	$223
Sanofi	12	$216
E.r. Squibb & Sons, L.L.C.	14	$201
Exelixis Inc.	9	$195
Stemline Therapeutics Inc.	8	$169
Bayer	10	$158
Eisai Inc.	8	$155
Lilly USA, LLC	10	$151
Sobi, Inc	6	$133
Karyopharm Therapeutics Inc.	6	$108
Blueprint Medicines Corporation	7	$105
AVEO Pharmaceuticals, Inc.	5	$100
Sanofi-aventis U.S. LLC	5	$99
Emmaus Medical, Inc.	5	$99
ADC Therapeutics America, Inc.	5	$97
GSK	6	$95
EMD Serono, Inc.	6	$88
Taiho Oncology, Inc.	3	$85
Pharmaessentia USA Corporation	4	$82
Immunocore Limited	3	$80
Boehringer Ingelheim	4	$69
Jazz Pharmaceuticals Inc.	3	$66
Adaptive Biotechnologies Corporation	3	$62
Array Biopharma Inc	4	$60
Ipsen Biopharmaceuticals, Inc	4	$59
Beone Medicines USA, Inc.	3	$54
Regeneron Healthcare Solutions, Inc.	3	$54
Beigene USA, Inc.	3	$48
Alnylam Pharmaceuticals Inc.	3	$47
Sanofi US Services Inc.	2	$40
G1 Therapeutics, Inc.	2	$36
Secura Bio, Inc.	3	$36
Coherus Oncology, Inc.	2	$36
Kyowa Kirin, Inc.	2	$34
Genmab U.S., Inc.	2	$33
Agios Pharmaceuticals, Inc.	2	$31
BD	2	$29
Teva Pharmaceuticals USA, Inc.	2	$24
Pharmacyclics LLC, An Abbvie Company	1	$24
Novo Nordisk	1	$23
Legend Biotech USA Inc.	1	$23
Acrotech Biopharma Inc.	1	$20
Myovant Sciences Inc.	1	$20
Kedrion Biopharma, Inc.	1	$19

How this compares

$134,698 in reported general payments places this provider in the 85th percentile of 57 hematology & oncology providers in Mississippi.

See all hematology & oncology providers in Mississippi →

Medicare billing

Part B allowed, 2024

$51,257

Medicare patients

258

Services billed

509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Jackson

Justin BakerJackson$2.1M
John HeneganJackson$1.2M
Carter MilnerJackson$261K
Guangzhi QuJackson$78K
Bobby WilkersonJackson$28K
Grace ShumakerJackson$10K
Katherine ThielJackson$2K
John HromHattiesburg$10M
Solly ChedidPascagoula$1.7M
Andrew KellumTupelo$171K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →